New Ask Claude or ChatGPT about any stock, using Bullpen. Bullpen in Claude or ChatGPT. 7 days free
Bullpen.News From Edwin Dorsey
Get Daily Recap Feedback

Friday, November 13, 2026

Back to the front page

From X

@calvinblissett

Calvin Blissett on X

Yes and no lol, valuation and dividend yield are attractive currently (I added a few days ago ~$88), macro continues to trend in the right direction, I do hate $PDD just entered Kazakhstan, BUT what I surface level read is they can coexist well and $KSPI has a different approach than them from someone who I think is smart, pretty sure was @Benceno88 if you may elaborate friend. Also $KSPI management team will continue to find ways to pull rabbits out of the hat and grow within KZ, the most recent grocery vertical being an example
@StableBread

Fajasy on X

DigiPowerX $DGXX said on October 13 that it "did not issue any shares" under its ATM program in Q3. $DGXX's Q3 10-Q, filed November 13, shows 2.85M shares issued for cash in Q3 for $11.3M, and counts them among the 30.8M shares it sold through the ATM in the first nine months of 2026. The share count rose 46% this year, from 69.4M at the end of 2025 to 101.4M as of November 12. The 10-Q also shows three details the Q3 earnings release left out: 1) Prepayment: Cerebras $CBRS, the AI chipmaker that's the tenant at $DGXX's Columbiana data center campus in Alabama, paid a $12M upfront charge in Q3 for building Phase 1. The charge can be refunded, less what's been spent on finished construction, in some cases before Phase 1 starts, including if $DGXX misses the final delivery date. 2) Spending: $145.5M went into property, equipment, and equipment deposits in the first nine months, paid for with $170.8M of net share sales. 3) GPUs: Equipment deposits rose to $23.9M from $8.5M at the end of 2025, and the 10-Q mentions next-generation $NVDA Vera Rubin systems $DGXX has "committed to purchase," without an amount. $DGXX's Q3 revenue rose 85% q/q to $12.2M, but its $1.0M of net income leaned on $8.6M of gains on its crypto and warrants. Cash was $95.2M and bitcoin and ether were $24.5M as of September 30. $DGXX also expects to close a $200M loan syndicated by Goldman Sachs $GS in Q4 2026 to finish Columbiana, with an unsecured $DGXX guarantee until construction is done. Even with the cash, crypto, and loan, $DGXX is ~$30M short of its 2027 plan (~$350M of capex, mostly for ~10 MW of AI inference capacity and Columbiana's Phase 2) before any Q4 2026 spending. $DGXX expects customer deposits and prepayments to be a main source of funding, and it has already sold $174.7M of the $175M its ATM prospectus covers. At $2.28/share, $DGXX's market cap is ~$231M, an EV of ~$112M after its cash and crypto. If Phase 1 is ready on December 15 as planned, Cerebras starts paying in January 2027, and its $12M prepayment can no longer be refunded.

Investor Letters

All letters
KRYS · short

Krystal Biotech INC

Krystal Biotech is a profitable commercial-stage biotech with an $8.7 billion enterprise value and one FDA-approved topical gene therapy,…

KRYS $9.2B
Value Investors Club 1 click

Under The Hood, ResMed ($RMD)

ResMed’s 30 million connected sleep-apnea patients, recurring masks and software support a data-driven healthcare platform; 11.9% annual…

RMD $34B
Bearhold Research 1 click

Publications we follow

Every publication on this site, hand-picked.

130 publications

Newsletters 110

YouTube 4

Blogs 15

Seeking Alpha 88 of 290

Nominate a publication

X accounts we follow

Every account on this site, hand-picked.

91 accounts
Nominate an account

Investor letters we follow

376 firms

Sectors

Ordered by how often our editor reaches for them.